Skip to main content

Siponimod

Therapy Area
Multiple Sclerosis - MS
API Technology
Synthetic
Formulation
Oral Solids
Development Status
Under-Development
Innovator Brand (US)
Not approved yet

We are here to help, if you have any country specific requirements - please Contact Us.